आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

mcdowell pharmaceuticals - tolterodine tartrate - prolonged release capsules - 4 milligram

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

pco manufacturing - tolterodine tartare - prolonged release capsules - 2 milligram

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

b & s healthcare - tolterodine l-tartrate - prolonged release capsules - 4 milligram

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 4 mg - tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see clinical studies (14)] . tolterodine tartrate extended-release capsules are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate extended-release capsules are also contraindicated in patients with known hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate extended-release capsules, are metabolized to 5-hydroxymethyl tolterodine [see warnings and precautions (5.2), ( 5.3), ( 5.4)] . at approximately 9 to 12 times the clinical exposure to the pharmacologically active components of tolterodine tartrate extended-release capsules, no anomalies or malformations were observed in mice (based on the auc of tolterodine and its 5-hmt metabolite at a dose of 20 mg/kg/day). at 14 to 18 times

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

mylan institutional inc. - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 2 mg - tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see clinical studies (14)] . tolterodine tartrate extended-release capsules are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate extended-release capsules are also contraindicated in patients with known hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate extended-release capsules, are metabolized to 5-hydroxymethyl tolterodine [see warnings and precautions (5.2), ( 5.3), ( 5.4)] . at approximately 9 to 12 times the clinical exposure to the pharmacolo

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see clinical studies (14)] . tolterodine tartrate extended-release capsules are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate extended-release capsules are also contraindicated in patients with known hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate extended-release capsules, are metabolized to 5-hydroxymethyl tolterodine [see warnings and precautions (5.2), ( 5.3), ( 5.4)] . at approximately 9 to 12 times the clinical exposure to the pharmacologically active components of tolterodine tartrate extended-release capsules, no anomalies or malformations were observed in mice (based on the auc of tolterodine and its 5-hmt metabolite at a dose of 20 mg/kg/day). at 14 to 18 times

कनाडा - अंग्रेज़ी - Health Canada

sandoz canada incorporated - silodosin - capsule - 4mg - silodosin 4mg - selective alfa-1-adrenergic blocking agents

कनाडा - अंग्रेज़ी - Health Canada

sandoz canada incorporated - silodosin - capsule - 8mg - silodosin 8mg - selective alfa-1-adrenergic blocking agents

कनाडा - अंग्रेज़ी - Health Canada

jamp pharma corporation - silodosin - capsule - 4mg - silodosin 4mg

कनाडा - अंग्रेज़ी - Health Canada

jamp pharma corporation - silodosin - capsule - 8mg - silodosin 8mg